Table 1. Published experience with the ICD in patients with hypertrophic cardiomyopathy in the previous 10 years.
| Author (Reference) | Year | Country | No. Patients | Mean Age at Implant | Appropriate Intervention no. (%) | Follow-Up (Years) | Intervention Rate (%) | Primary Prevention Patients (%) | Inappropriate Shocks (%) |
|---|---|---|---|---|---|---|---|---|---|
| Primo20 | 1998 | Belgium; Spain | 13 | 48 | 2 (15) | 2.1 | 7.1 | 0 | 23 |
| Maron10 | 2000 | United States/ Europe | 128 | 40 | 29 (23) | 3.1 | 7.0 | 66 | 25 |
| Begley39 | 2003 | United States | 132 | 34 | 27 (20) | 4.8 | 4.2* | 64 | 23 |
| Jayatilleke12 | 2004 | Australia | 22 | 36 | 7 (32) | 2.9 | 11.0 | 82 | 9 |
| Przybylski17 | 2005 | Poland | 46 | 32 | 13 (28) | 2.3 | 12.2 | 61 | 30 |
| Marin16 | 2006 | Spain | 45 | 43 | 10 (22) | 1.5 | 11.0 | 60 | 26 |
| Kaski21 | 2007 | United Kingdom | 22 | 14 | 4 (18) | 1.7 | 10.6 | 77 | 18 |
| Maron11 | 2007 | United States/ Australia/Europe | 506 | 42 | 103 (20) | 3.7 | 5.5 | 76 | 27 |
Notes.
*
Criteria used for validating those arrhythmias triggering the implantable cardioverter-defibrillator (ICD) are not specified.